Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35462
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pena A.S. | en |
dc.contributor.author | Teede H.J. | en |
dc.contributor.author | Witchel S.F. | en |
dc.date.accessioned | 2021-05-14T11:59:00Z | en |
dc.date.available | 2021-05-14T11:59:00Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20200123 | en |
dc.date.issued | 2020-01-23 | en |
dc.identifier.citation | Pediatric Research. 87 (2) (pp 353-361), 2020. Date of Publication: 01 Jan 2020. | en |
dc.identifier.issn | 0031-3998 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/35462 | en |
dc.description.abstract | Polycystic ovary syndrome (PCOS), characterized by hormonal imbalance and ovarian dysfunction, often starts during adolescence. Inconsistent diagnostic criteria, variable provider knowledge, and lack of consensus pose specific challenges for the care of women with PCOS. These factors encourage inaccurate diagnosis with both under and overdiagnosis. This unfavorable diagnostic experience exasperates affected women and limits timely opportunities for intervention to minimize associated comorbidities, especially during the transition from pediatric to adult care. Recognition of these issues in the care of adolescents and women with PCOS inspired the development of the International Evidence-Based PCOS Guidelines, which emphasize the prevention, screening, and treatment of PCOS across the reproductive lifespan. The Guidelines and accompanying meta-analyses focus on three major categories of associated comorbidities: (1) reproductive; (2) metabolic; and (3) psychological. With the exception of infertility, this article considers common manifestations and comorbidities associated with PCOS throughout the lifecycle. Healthy lifestyle interventions with prevention of excess weight gain comprise the primary intervention for all comorbidities. Hence, early identification of girls "at risk" for PCOS and those with PCOS is a priority. Extensive guidelines for provider and patient education aim to decrease the medical, psychosocial, and economic burdens attributable to PCOS and its associated comorbidities.Copyright © 2019, International Pediatric Research Foundation, Inc. | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Springer Nature | en |
dc.relation.ispartof | Pediatric Research | en |
dc.subject.mesh | eating disorder | - |
dc.subject.mesh | adolescence | - |
dc.subject.mesh | amenorrhea | - |
dc.subject.mesh | anovulation | - |
dc.subject.mesh | anxiety disorder | - |
dc.subject.mesh | attributable risk | - |
dc.subject.mesh | body mass | - |
dc.subject.mesh | body weight gain | - |
dc.subject.mesh | cancer risk | - |
dc.subject.mesh | depression | - |
dc.subject.mesh | endometrium cancer | - |
dc.subject.mesh | environmental factor | - |
dc.subject.mesh | epigenetics | - |
dc.subject.mesh | evidence based practice | - |
dc.subject.mesh | infertility | - |
dc.subject.mesh | healthy lifestyle | - |
dc.subject.mesh | hirsutism | - |
dc.subject.mesh | hyperandrogenism | - |
dc.subject.mesh | hyperglycemia | - |
dc.subject.mesh | impaired glucose tolerance | - |
dc.subject.mesh | insulin resistance | - |
dc.subject.mesh | maternal obesity | - |
dc.subject.mesh | metabolic disorder | - |
dc.subject.mesh | mother fetus relationship | - |
dc.subject.mesh | non insulin dependent diabetes mellitus | - |
dc.subject.mesh | ovary insufficiency | - |
dc.subject.mesh | ovary polycystic disease | - |
dc.subject.mesh | pathophysiology | - |
dc.subject.mesh | patient education | - |
dc.subject.mesh | physical disease by body function | - |
dc.subject.mesh | practice guideline | - |
dc.subject.mesh | pregnancy | - |
dc.subject.mesh | pregnancy diabetes mellitus | - |
dc.subject.mesh | psychological aspect | - |
dc.subject.mesh | quality of life | - |
dc.subject.mesh | skin disease | - |
dc.subject.mesh | sleep disordered breathing | - |
dc.subject.mesh | transition to care | - |
dc.subject.mesh | androgen | - |
dc.subject.mesh | estrogen | - |
dc.subject.mesh | insulin | - |
dc.title | Curtailing PCOS. | en |
dc.type | Review | en |
dc.identifier.affiliation | Endocrinology | - |
dc.identifier.affiliation | Diabetes and Vascular Medicine | - |
dc.type.studyortrial | Systematic review and/or meta-analysis | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/s41390-019-0615-1 | - |
dc.publisher.place | United States | en |
dc.identifier.pubmedid | 31627209 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31627209] | en |
dc.identifier.source | 2003536420 | en |
dc.identifier.institution | (Witchel) Department of Pediatrics, Division of Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, United States (Teede) Department of Endocrinology and Diabetes, Monash Health, Clayton, VIC, Australia (Teede) Monash Centre for Health Research and Implementation, School of Public Health and Preventative Medicine, Monash University, Clayton, VIC, Australia (Pena) Discipline of Paediatrics, The University of Adelaide-Robinson Research Institute, North Adelaide, SA, Australia | en |
dc.description.address | S.F. Witchel, Department of Pediatrics, Division of Pediatric Endocrinology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, United States. E-mail: selma.witchel@chp.edu | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.identifier.authoremail | Witchel S.F.; selma.witchel@chp.edu | en |
item.fulltext | No Fulltext | - |
item.openairetype | Review | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Diabetes and Vascular Medicine | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.